Global Antimalarial Drug

Antimalarial Drug Comprehensive Study by Type (Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, Others), Application (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others), Distribution Channel (Online, Medical Stores, Pharmaceuticals, Others), Form (Tablet, Capsule), Parasite Type (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae, Plasmodium Ovale) Players and Region - Global Market Outlook to 2028

Antimalarial Drug Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Antimalarial Drug Market?

Malaria is a very highly infectious disease, which usually spreads through a bite of an infected female Anopheles mosquito, by transferring parasites into the human body. Furthermore, these parasites then lodge into the liver cells where they can easily multiply and grow. They then move towards the red blood cells to reach a stage commonly called merozoites. These merozoites further grow inside the red blood cells and then destroy them which further causes the symptoms such as tiredness, fever, vomiting, and headache. In addition, to these, the drugs that are usually used for the treatment and prevention of malarial infection are known as antimalarial drugs. Antimalarial drugs are such agents that are commonly used for treating malaria. If at all an infected anopheles mosquito bites a healthy person, then the infection of a definite protozoan is transmitted into the person. Malaria can be therefore prevented by the usage of the antimalarial drugs in the form of a prophylactic measure before entering into an endemic area. Different antimalarial drugs are used for the various stages of the complete life cycle of the parasite. Some of the antimalarial drugs are very effective against the acute attack of malaria, while some of them are used as prophylactic agents that help in killing the parasite when it enters into the host body. A combination of the drugs are also available for the treatment of malaria. There are various types of drugs, like quinine, proguanil, chloroquine, pyrimethamine, mefloquine, and others, that are available in the market for the purpose of treatment of the malarial infection.

Highlights from Antimalarial Drug Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledPfizer (United States), GlaxoSmithKline (United Kingdom), Ranbaxy Laboratories (India), Ipca Laboratories Ltd (India), Zydus Cadila (India), Merck KGaA (Germany), Novartis AG (Switzerland), Alvizia Health Care (India), Bayer (Germany) and Roche Holding AG (Switzerland)


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Antimalarial Drug market throughout the forecasted period.

Pfizer (United States), GlaxoSmithKline (United Kingdom), Ranbaxy Laboratories (India), Ipca Laboratories Ltd (India), Zydus Cadila (India), Merck KGaA (Germany), Novartis AG (Switzerland), Alvizia Health Care (India), Bayer (Germany) and Roche Holding AG (Switzerland) are some of the key players profiled in the study.

Antimalarial Drug Market Segmentation:
ScopeSub-Segments
Application / End UserHospital Pharmacy, Retail Pharmacy, E-Commerce and Others
TypeQuinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine and Others
Distribution ChannelOnline,Medical Stores,Pharmaceuticals,Others
FormTablet,Capsule
Parasite TypePlasmodium Falciparum,Plasmodium Vivax,Plasmodium Malariae,Plasmodium Ovale


On the basis of geography, the market of Antimalarial Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Healthcare Spending and Demand for Drug Therapy

Market Growth Drivers:
Growing Geriatric Population in Major Economies, A Rise In The Prevalence Of Malaria In Developing Countries and The Increasing Awareness Initiatives By Governments And Surge In Research For New Antimalarial Drugs

Challenges:
Availability of Substitutes and Lack Of Awareness About Healthcare

Restraints:
Stringent Government Rules and Regulation and Side Effects Due to Antimalarial Drug

Opportunities:
Research and Development and Product Innovation and Potential Growth From Emerging Countries

Key Target Audience
Manufacturers of Antimalarial Drug, Suppliers and Distributors of Antimalarial Drug, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others

Market Leaders & Development Strategies
In December 2021, Pfizer acquired Arena Pharmaceuticals with USD 6.7 billion in cash. This acquisition helped company to expand its presence in antimalarial drug market
In December 2021, GSK plc welcomed the decision of the Gavi Board to provide funding for the procurement and introduction of malaria vaccines into routine child immunisation programmes in Gavi eligible countries. This helped company helped to expand its presence in antimalarial drug market


Report Objectives / Segmentation Covered

By Type
  • Quinine
  • Chloroquine
  • Proguanil
  • Mefloquine
  • Pyrimethamine
  • Others
By Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
  • Others
By Distribution Channel
  • Online
  • Medical Stores
  • Pharmaceuticals
  • Others

By Form
  • Tablet
  • Capsule

By Parasite Type
  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Plasmodium Malariae
  • Plasmodium Ovale

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population in Major Economies
      • 3.2.2. A Rise In The Prevalence Of Malaria In Developing Countries
      • 3.2.3. The Increasing Awareness Initiatives By Governments And Surge In Research For New Antimalarial Drugs
    • 3.3. Market Challenges
      • 3.3.1. Availability of Substitutes
      • 3.3.2. Lack Of Awareness About Healthcare
    • 3.4. Market Trends
      • 3.4.1. Increasing Healthcare Spending and Demand for Drug Therapy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antimalarial Drug, by Type, Application, Distribution Channel, Form, Parasite Type and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antimalarial Drug (Value)
      • 5.2.1. Global Antimalarial Drug by: Type (Value)
        • 5.2.1.1. Quinine
        • 5.2.1.2. Chloroquine
        • 5.2.1.3. Proguanil
        • 5.2.1.4. Mefloquine
        • 5.2.1.5. Pyrimethamine
        • 5.2.1.6. Others
      • 5.2.2. Global Antimalarial Drug by: Application (Value)
        • 5.2.2.1. Hospital Pharmacy
        • 5.2.2.2. Retail Pharmacy
        • 5.2.2.3. E-Commerce
        • 5.2.2.4. Others
      • 5.2.3. Global Antimalarial Drug by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Medical Stores
        • 5.2.3.3. Pharmaceuticals
        • 5.2.3.4. Others
      • 5.2.4. Global Antimalarial Drug by: Form (Value)
        • 5.2.4.1. Tablet
        • 5.2.4.2. Capsule
      • 5.2.5. Global Antimalarial Drug by: Parasite Type (Value)
        • 5.2.5.1. Plasmodium Falciparum
        • 5.2.5.2. Plasmodium Vivax
        • 5.2.5.3. Plasmodium Malariae
        • 5.2.5.4. Plasmodium Ovale
      • 5.2.6. Global Antimalarial Drug Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Antimalarial Drug (Volume)
      • 5.3.1. Global Antimalarial Drug by: Type (Volume)
        • 5.3.1.1. Quinine
        • 5.3.1.2. Chloroquine
        • 5.3.1.3. Proguanil
        • 5.3.1.4. Mefloquine
        • 5.3.1.5. Pyrimethamine
        • 5.3.1.6. Others
      • 5.3.2. Global Antimalarial Drug by: Application (Volume)
        • 5.3.2.1. Hospital Pharmacy
        • 5.3.2.2. Retail Pharmacy
        • 5.3.2.3. E-Commerce
        • 5.3.2.4. Others
      • 5.3.3. Global Antimalarial Drug by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Medical Stores
        • 5.3.3.3. Pharmaceuticals
        • 5.3.3.4. Others
      • 5.3.4. Global Antimalarial Drug by: Form (Volume)
        • 5.3.4.1. Tablet
        • 5.3.4.2. Capsule
      • 5.3.5. Global Antimalarial Drug by: Parasite Type (Volume)
        • 5.3.5.1. Plasmodium Falciparum
        • 5.3.5.2. Plasmodium Vivax
        • 5.3.5.3. Plasmodium Malariae
        • 5.3.5.4. Plasmodium Ovale
      • 5.3.6. Global Antimalarial Drug Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Antimalarial Drug (Price)
      • 5.4.1. Global Antimalarial Drug by: Type (Price)
  • 6. Antimalarial Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ranbaxy Laboratories (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ipca Laboratories Ltd (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zydus Cadila (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck KGaA (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Alvizia Health Care (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bayer (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Roche Holding AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antimalarial Drug Sale, by Type, Application, Distribution Channel, Form, Parasite Type and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antimalarial Drug (Value)
      • 7.2.1. Global Antimalarial Drug by: Type (Value)
        • 7.2.1.1. Quinine
        • 7.2.1.2. Chloroquine
        • 7.2.1.3. Proguanil
        • 7.2.1.4. Mefloquine
        • 7.2.1.5. Pyrimethamine
        • 7.2.1.6. Others
      • 7.2.2. Global Antimalarial Drug by: Application (Value)
        • 7.2.2.1. Hospital Pharmacy
        • 7.2.2.2. Retail Pharmacy
        • 7.2.2.3. E-Commerce
        • 7.2.2.4. Others
      • 7.2.3. Global Antimalarial Drug by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Medical Stores
        • 7.2.3.3. Pharmaceuticals
        • 7.2.3.4. Others
      • 7.2.4. Global Antimalarial Drug by: Form (Value)
        • 7.2.4.1. Tablet
        • 7.2.4.2. Capsule
      • 7.2.5. Global Antimalarial Drug by: Parasite Type (Value)
        • 7.2.5.1. Plasmodium Falciparum
        • 7.2.5.2. Plasmodium Vivax
        • 7.2.5.3. Plasmodium Malariae
        • 7.2.5.4. Plasmodium Ovale
      • 7.2.6. Global Antimalarial Drug Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Antimalarial Drug (Volume)
      • 7.3.1. Global Antimalarial Drug by: Type (Volume)
        • 7.3.1.1. Quinine
        • 7.3.1.2. Chloroquine
        • 7.3.1.3. Proguanil
        • 7.3.1.4. Mefloquine
        • 7.3.1.5. Pyrimethamine
        • 7.3.1.6. Others
      • 7.3.2. Global Antimalarial Drug by: Application (Volume)
        • 7.3.2.1. Hospital Pharmacy
        • 7.3.2.2. Retail Pharmacy
        • 7.3.2.3. E-Commerce
        • 7.3.2.4. Others
      • 7.3.3. Global Antimalarial Drug by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Medical Stores
        • 7.3.3.3. Pharmaceuticals
        • 7.3.3.4. Others
      • 7.3.4. Global Antimalarial Drug by: Form (Volume)
        • 7.3.4.1. Tablet
        • 7.3.4.2. Capsule
      • 7.3.5. Global Antimalarial Drug by: Parasite Type (Volume)
        • 7.3.5.1. Plasmodium Falciparum
        • 7.3.5.2. Plasmodium Vivax
        • 7.3.5.3. Plasmodium Malariae
        • 7.3.5.4. Plasmodium Ovale
      • 7.3.6. Global Antimalarial Drug Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Antimalarial Drug (Price)
      • 7.4.1. Global Antimalarial Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antimalarial Drug: by Type(USD Million)
  • Table 2. Antimalarial Drug Quinine , by Region USD Million (2017-2022)
  • Table 3. Antimalarial Drug Chloroquine , by Region USD Million (2017-2022)
  • Table 4. Antimalarial Drug Proguanil , by Region USD Million (2017-2022)
  • Table 5. Antimalarial Drug Mefloquine , by Region USD Million (2017-2022)
  • Table 6. Antimalarial Drug Pyrimethamine , by Region USD Million (2017-2022)
  • Table 7. Antimalarial Drug Others , by Region USD Million (2017-2022)
  • Table 8. Antimalarial Drug: by Application(USD Million)
  • Table 9. Antimalarial Drug Hospital Pharmacy , by Region USD Million (2017-2022)
  • Table 10. Antimalarial Drug Retail Pharmacy , by Region USD Million (2017-2022)
  • Table 11. Antimalarial Drug E-Commerce , by Region USD Million (2017-2022)
  • Table 12. Antimalarial Drug Others , by Region USD Million (2017-2022)
  • Table 13. Antimalarial Drug: by Distribution Channel(USD Million)
  • Table 14. Antimalarial Drug Online , by Region USD Million (2017-2022)
  • Table 15. Antimalarial Drug Medical Stores , by Region USD Million (2017-2022)
  • Table 16. Antimalarial Drug Pharmaceuticals , by Region USD Million (2017-2022)
  • Table 17. Antimalarial Drug Others , by Region USD Million (2017-2022)
  • Table 18. Antimalarial Drug: by Form(USD Million)
  • Table 19. Antimalarial Drug Tablet , by Region USD Million (2017-2022)
  • Table 20. Antimalarial Drug Capsule , by Region USD Million (2017-2022)
  • Table 21. Antimalarial Drug: by Parasite Type(USD Million)
  • Table 22. Antimalarial Drug Plasmodium Falciparum , by Region USD Million (2017-2022)
  • Table 23. Antimalarial Drug Plasmodium Vivax , by Region USD Million (2017-2022)
  • Table 24. Antimalarial Drug Plasmodium Malariae , by Region USD Million (2017-2022)
  • Table 25. Antimalarial Drug Plasmodium Ovale , by Region USD Million (2017-2022)
  • Table 26. South America Antimalarial Drug, by Country USD Million (2017-2022)
  • Table 27. South America Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 28. South America Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 29. South America Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 30. South America Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 31. South America Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 32. Brazil Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 33. Brazil Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 34. Brazil Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 35. Brazil Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 36. Brazil Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 37. Argentina Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 38. Argentina Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 39. Argentina Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 40. Argentina Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 41. Argentina Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 42. Rest of South America Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 43. Rest of South America Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 44. Rest of South America Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 45. Rest of South America Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 46. Rest of South America Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 47. Asia Pacific Antimalarial Drug, by Country USD Million (2017-2022)
  • Table 48. Asia Pacific Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 49. Asia Pacific Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 50. Asia Pacific Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 51. Asia Pacific Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 52. Asia Pacific Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 53. China Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 54. China Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 55. China Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 56. China Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 57. China Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 58. Japan Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 59. Japan Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 60. Japan Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 61. Japan Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 62. Japan Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 63. India Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 64. India Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 65. India Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 66. India Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 67. India Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 68. South Korea Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 69. South Korea Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 70. South Korea Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 71. South Korea Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 72. South Korea Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 73. Taiwan Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 74. Taiwan Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 75. Taiwan Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 76. Taiwan Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 77. Taiwan Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 78. Australia Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 79. Australia Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 80. Australia Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 81. Australia Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 82. Australia Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 86. Rest of Asia-Pacific Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 87. Rest of Asia-Pacific Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 88. Europe Antimalarial Drug, by Country USD Million (2017-2022)
  • Table 89. Europe Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 90. Europe Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 91. Europe Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 92. Europe Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 93. Europe Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 94. Germany Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 95. Germany Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 96. Germany Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 97. Germany Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 98. Germany Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 99. France Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 100. France Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 101. France Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 102. France Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 103. France Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 104. Italy Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 105. Italy Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 106. Italy Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 107. Italy Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 108. Italy Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 109. United Kingdom Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 110. United Kingdom Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 111. United Kingdom Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 112. United Kingdom Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 113. United Kingdom Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 114. Netherlands Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 115. Netherlands Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 116. Netherlands Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 117. Netherlands Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 118. Netherlands Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 119. Rest of Europe Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 120. Rest of Europe Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 121. Rest of Europe Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 122. Rest of Europe Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 123. Rest of Europe Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 124. MEA Antimalarial Drug, by Country USD Million (2017-2022)
  • Table 125. MEA Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 126. MEA Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 127. MEA Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 128. MEA Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 129. MEA Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 130. Middle East Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 131. Middle East Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 132. Middle East Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 133. Middle East Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 134. Middle East Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 135. Africa Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 136. Africa Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 137. Africa Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 138. Africa Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 139. Africa Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 140. North America Antimalarial Drug, by Country USD Million (2017-2022)
  • Table 141. North America Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 142. North America Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 143. North America Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 144. North America Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 145. North America Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 146. United States Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 147. United States Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 148. United States Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 149. United States Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 150. United States Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 151. Canada Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 152. Canada Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 153. Canada Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 154. Canada Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 155. Canada Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 156. Mexico Antimalarial Drug, by Type USD Million (2017-2022)
  • Table 157. Mexico Antimalarial Drug, by Application USD Million (2017-2022)
  • Table 158. Mexico Antimalarial Drug, by Distribution Channel USD Million (2017-2022)
  • Table 159. Mexico Antimalarial Drug, by Form USD Million (2017-2022)
  • Table 160. Mexico Antimalarial Drug, by Parasite Type USD Million (2017-2022)
  • Table 161. Antimalarial Drug Sales: by Type(K Tons)
  • Table 162. Antimalarial Drug Sales Quinine , by Region K Tons (2017-2022)
  • Table 163. Antimalarial Drug Sales Chloroquine , by Region K Tons (2017-2022)
  • Table 164. Antimalarial Drug Sales Proguanil , by Region K Tons (2017-2022)
  • Table 165. Antimalarial Drug Sales Mefloquine , by Region K Tons (2017-2022)
  • Table 166. Antimalarial Drug Sales Pyrimethamine , by Region K Tons (2017-2022)
  • Table 167. Antimalarial Drug Sales Others , by Region K Tons (2017-2022)
  • Table 168. Antimalarial Drug Sales: by Application(K Tons)
  • Table 169. Antimalarial Drug Sales Hospital Pharmacy , by Region K Tons (2017-2022)
  • Table 170. Antimalarial Drug Sales Retail Pharmacy , by Region K Tons (2017-2022)
  • Table 171. Antimalarial Drug Sales E-Commerce , by Region K Tons (2017-2022)
  • Table 172. Antimalarial Drug Sales Others , by Region K Tons (2017-2022)
  • Table 173. Antimalarial Drug Sales: by Distribution Channel(K Tons)
  • Table 174. Antimalarial Drug Sales Online , by Region K Tons (2017-2022)
  • Table 175. Antimalarial Drug Sales Medical Stores , by Region K Tons (2017-2022)
  • Table 176. Antimalarial Drug Sales Pharmaceuticals , by Region K Tons (2017-2022)
  • Table 177. Antimalarial Drug Sales Others , by Region K Tons (2017-2022)
  • Table 178. Antimalarial Drug Sales: by Form(K Tons)
  • Table 179. Antimalarial Drug Sales Tablet , by Region K Tons (2017-2022)
  • Table 180. Antimalarial Drug Sales Capsule , by Region K Tons (2017-2022)
  • Table 181. Antimalarial Drug Sales: by Parasite Type(K Tons)
  • Table 182. Antimalarial Drug Sales Plasmodium Falciparum , by Region K Tons (2017-2022)
  • Table 183. Antimalarial Drug Sales Plasmodium Vivax , by Region K Tons (2017-2022)
  • Table 184. Antimalarial Drug Sales Plasmodium Malariae , by Region K Tons (2017-2022)
  • Table 185. Antimalarial Drug Sales Plasmodium Ovale , by Region K Tons (2017-2022)
  • Table 186. South America Antimalarial Drug Sales, by Country K Tons (2017-2022)
  • Table 187. South America Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 188. South America Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 189. South America Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 190. South America Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 191. South America Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 192. Brazil Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 193. Brazil Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 194. Brazil Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 195. Brazil Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 196. Brazil Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 197. Argentina Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 198. Argentina Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 199. Argentina Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 200. Argentina Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 201. Argentina Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 202. Rest of South America Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 203. Rest of South America Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 204. Rest of South America Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 205. Rest of South America Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 206. Rest of South America Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 207. Asia Pacific Antimalarial Drug Sales, by Country K Tons (2017-2022)
  • Table 208. Asia Pacific Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 209. Asia Pacific Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 210. Asia Pacific Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 211. Asia Pacific Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 212. Asia Pacific Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 213. China Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 214. China Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 215. China Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 216. China Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 217. China Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 218. Japan Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 219. Japan Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 220. Japan Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 221. Japan Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 222. Japan Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 223. India Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 224. India Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 225. India Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 226. India Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 227. India Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 228. South Korea Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 229. South Korea Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 230. South Korea Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 231. South Korea Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 232. South Korea Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 233. Taiwan Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 234. Taiwan Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 235. Taiwan Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 236. Taiwan Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 237. Taiwan Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 238. Australia Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 239. Australia Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 240. Australia Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 241. Australia Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 242. Australia Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 243. Rest of Asia-Pacific Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 244. Rest of Asia-Pacific Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 245. Rest of Asia-Pacific Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 246. Rest of Asia-Pacific Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 247. Rest of Asia-Pacific Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 248. Europe Antimalarial Drug Sales, by Country K Tons (2017-2022)
  • Table 249. Europe Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 250. Europe Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 251. Europe Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 252. Europe Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 253. Europe Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 254. Germany Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 255. Germany Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 256. Germany Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 257. Germany Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 258. Germany Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 259. France Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 260. France Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 261. France Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 262. France Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 263. France Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 264. Italy Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 265. Italy Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 266. Italy Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 267. Italy Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 268. Italy Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 269. United Kingdom Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 270. United Kingdom Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 271. United Kingdom Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 272. United Kingdom Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 273. United Kingdom Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 274. Netherlands Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 275. Netherlands Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 276. Netherlands Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 277. Netherlands Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 278. Netherlands Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 279. Rest of Europe Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 280. Rest of Europe Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 281. Rest of Europe Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 282. Rest of Europe Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 283. Rest of Europe Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 284. MEA Antimalarial Drug Sales, by Country K Tons (2017-2022)
  • Table 285. MEA Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 286. MEA Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 287. MEA Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 288. MEA Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 289. MEA Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 290. Middle East Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 291. Middle East Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 292. Middle East Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 293. Middle East Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 294. Middle East Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 295. Africa Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 296. Africa Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 297. Africa Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 298. Africa Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 299. Africa Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 300. North America Antimalarial Drug Sales, by Country K Tons (2017-2022)
  • Table 301. North America Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 302. North America Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 303. North America Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 304. North America Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 305. North America Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 306. United States Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 307. United States Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 308. United States Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 309. United States Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 310. United States Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 311. Canada Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 312. Canada Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 313. Canada Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 314. Canada Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 315. Canada Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 316. Mexico Antimalarial Drug Sales, by Type K Tons (2017-2022)
  • Table 317. Mexico Antimalarial Drug Sales, by Application K Tons (2017-2022)
  • Table 318. Mexico Antimalarial Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 319. Mexico Antimalarial Drug Sales, by Form K Tons (2017-2022)
  • Table 320. Mexico Antimalarial Drug Sales, by Parasite Type K Tons (2017-2022)
  • Table 321. Antimalarial Drug: by Type(USD/Units)
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Company Basic Information, Sales Area and Its Competitors
  • Table 332. Antimalarial Drug: by Type(USD Million)
  • Table 333. Antimalarial Drug Quinine , by Region USD Million (2023-2028)
  • Table 334. Antimalarial Drug Chloroquine , by Region USD Million (2023-2028)
  • Table 335. Antimalarial Drug Proguanil , by Region USD Million (2023-2028)
  • Table 336. Antimalarial Drug Mefloquine , by Region USD Million (2023-2028)
  • Table 337. Antimalarial Drug Pyrimethamine , by Region USD Million (2023-2028)
  • Table 338. Antimalarial Drug Others , by Region USD Million (2023-2028)
  • Table 339. Antimalarial Drug: by Application(USD Million)
  • Table 340. Antimalarial Drug Hospital Pharmacy , by Region USD Million (2023-2028)
  • Table 341. Antimalarial Drug Retail Pharmacy , by Region USD Million (2023-2028)
  • Table 342. Antimalarial Drug E-Commerce , by Region USD Million (2023-2028)
  • Table 343. Antimalarial Drug Others , by Region USD Million (2023-2028)
  • Table 344. Antimalarial Drug: by Distribution Channel(USD Million)
  • Table 345. Antimalarial Drug Online , by Region USD Million (2023-2028)
  • Table 346. Antimalarial Drug Medical Stores , by Region USD Million (2023-2028)
  • Table 347. Antimalarial Drug Pharmaceuticals , by Region USD Million (2023-2028)
  • Table 348. Antimalarial Drug Others , by Region USD Million (2023-2028)
  • Table 349. Antimalarial Drug: by Form(USD Million)
  • Table 350. Antimalarial Drug Tablet , by Region USD Million (2023-2028)
  • Table 351. Antimalarial Drug Capsule , by Region USD Million (2023-2028)
  • Table 352. Antimalarial Drug: by Parasite Type(USD Million)
  • Table 353. Antimalarial Drug Plasmodium Falciparum , by Region USD Million (2023-2028)
  • Table 354. Antimalarial Drug Plasmodium Vivax , by Region USD Million (2023-2028)
  • Table 355. Antimalarial Drug Plasmodium Malariae , by Region USD Million (2023-2028)
  • Table 356. Antimalarial Drug Plasmodium Ovale , by Region USD Million (2023-2028)
  • Table 357. South America Antimalarial Drug, by Country USD Million (2023-2028)
  • Table 358. South America Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 359. South America Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 360. South America Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 361. South America Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 362. South America Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 363. Brazil Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 364. Brazil Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 365. Brazil Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 366. Brazil Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 367. Brazil Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 368. Argentina Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 369. Argentina Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 370. Argentina Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 371. Argentina Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 372. Argentina Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 373. Rest of South America Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 374. Rest of South America Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 375. Rest of South America Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 376. Rest of South America Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 377. Rest of South America Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 378. Asia Pacific Antimalarial Drug, by Country USD Million (2023-2028)
  • Table 379. Asia Pacific Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 380. Asia Pacific Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 381. Asia Pacific Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 382. Asia Pacific Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 383. Asia Pacific Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 384. China Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 385. China Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 386. China Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 387. China Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 388. China Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 389. Japan Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 390. Japan Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 391. Japan Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 392. Japan Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 393. Japan Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 394. India Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 395. India Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 396. India Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 397. India Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 398. India Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 399. South Korea Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 400. South Korea Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 401. South Korea Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 402. South Korea Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 403. South Korea Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 404. Taiwan Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 405. Taiwan Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 406. Taiwan Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 407. Taiwan Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 408. Taiwan Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 409. Australia Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 410. Australia Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 411. Australia Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 412. Australia Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 413. Australia Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 414. Rest of Asia-Pacific Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 415. Rest of Asia-Pacific Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 416. Rest of Asia-Pacific Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 417. Rest of Asia-Pacific Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 418. Rest of Asia-Pacific Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 419. Europe Antimalarial Drug, by Country USD Million (2023-2028)
  • Table 420. Europe Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 421. Europe Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 422. Europe Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 423. Europe Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 424. Europe Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 425. Germany Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 426. Germany Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 427. Germany Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 428. Germany Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 429. Germany Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 430. France Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 431. France Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 432. France Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 433. France Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 434. France Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 435. Italy Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 436. Italy Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 437. Italy Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 438. Italy Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 439. Italy Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 440. United Kingdom Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 441. United Kingdom Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 442. United Kingdom Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 443. United Kingdom Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 444. United Kingdom Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 445. Netherlands Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 446. Netherlands Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 447. Netherlands Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 448. Netherlands Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 449. Netherlands Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 450. Rest of Europe Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 451. Rest of Europe Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 452. Rest of Europe Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 453. Rest of Europe Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 454. Rest of Europe Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 455. MEA Antimalarial Drug, by Country USD Million (2023-2028)
  • Table 456. MEA Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 457. MEA Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 458. MEA Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 459. MEA Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 460. MEA Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 461. Middle East Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 462. Middle East Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 463. Middle East Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 464. Middle East Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 465. Middle East Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 466. Africa Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 467. Africa Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 468. Africa Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 469. Africa Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 470. Africa Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 471. North America Antimalarial Drug, by Country USD Million (2023-2028)
  • Table 472. North America Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 473. North America Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 474. North America Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 475. North America Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 476. North America Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 477. United States Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 478. United States Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 479. United States Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 480. United States Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 481. United States Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 482. Canada Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 483. Canada Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 484. Canada Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 485. Canada Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 486. Canada Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 487. Mexico Antimalarial Drug, by Type USD Million (2023-2028)
  • Table 488. Mexico Antimalarial Drug, by Application USD Million (2023-2028)
  • Table 489. Mexico Antimalarial Drug, by Distribution Channel USD Million (2023-2028)
  • Table 490. Mexico Antimalarial Drug, by Form USD Million (2023-2028)
  • Table 491. Mexico Antimalarial Drug, by Parasite Type USD Million (2023-2028)
  • Table 492. Antimalarial Drug Sales: by Type(K Tons)
  • Table 493. Antimalarial Drug Sales Quinine , by Region K Tons (2023-2028)
  • Table 494. Antimalarial Drug Sales Chloroquine , by Region K Tons (2023-2028)
  • Table 495. Antimalarial Drug Sales Proguanil , by Region K Tons (2023-2028)
  • Table 496. Antimalarial Drug Sales Mefloquine , by Region K Tons (2023-2028)
  • Table 497. Antimalarial Drug Sales Pyrimethamine , by Region K Tons (2023-2028)
  • Table 498. Antimalarial Drug Sales Others , by Region K Tons (2023-2028)
  • Table 499. Antimalarial Drug Sales: by Application(K Tons)
  • Table 500. Antimalarial Drug Sales Hospital Pharmacy , by Region K Tons (2023-2028)
  • Table 501. Antimalarial Drug Sales Retail Pharmacy , by Region K Tons (2023-2028)
  • Table 502. Antimalarial Drug Sales E-Commerce , by Region K Tons (2023-2028)
  • Table 503. Antimalarial Drug Sales Others , by Region K Tons (2023-2028)
  • Table 504. Antimalarial Drug Sales: by Distribution Channel(K Tons)
  • Table 505. Antimalarial Drug Sales Online , by Region K Tons (2023-2028)
  • Table 506. Antimalarial Drug Sales Medical Stores , by Region K Tons (2023-2028)
  • Table 507. Antimalarial Drug Sales Pharmaceuticals , by Region K Tons (2023-2028)
  • Table 508. Antimalarial Drug Sales Others , by Region K Tons (2023-2028)
  • Table 509. Antimalarial Drug Sales: by Form(K Tons)
  • Table 510. Antimalarial Drug Sales Tablet , by Region K Tons (2023-2028)
  • Table 511. Antimalarial Drug Sales Capsule , by Region K Tons (2023-2028)
  • Table 512. Antimalarial Drug Sales: by Parasite Type(K Tons)
  • Table 513. Antimalarial Drug Sales Plasmodium Falciparum , by Region K Tons (2023-2028)
  • Table 514. Antimalarial Drug Sales Plasmodium Vivax , by Region K Tons (2023-2028)
  • Table 515. Antimalarial Drug Sales Plasmodium Malariae , by Region K Tons (2023-2028)
  • Table 516. Antimalarial Drug Sales Plasmodium Ovale , by Region K Tons (2023-2028)
  • Table 517. South America Antimalarial Drug Sales, by Country K Tons (2023-2028)
  • Table 518. South America Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 519. South America Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 520. South America Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 521. South America Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 522. South America Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 523. Brazil Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 524. Brazil Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 525. Brazil Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 526. Brazil Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 527. Brazil Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 528. Argentina Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 529. Argentina Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 530. Argentina Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 531. Argentina Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 532. Argentina Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 533. Rest of South America Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 534. Rest of South America Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 535. Rest of South America Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 536. Rest of South America Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 537. Rest of South America Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 538. Asia Pacific Antimalarial Drug Sales, by Country K Tons (2023-2028)
  • Table 539. Asia Pacific Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 540. Asia Pacific Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 541. Asia Pacific Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 542. Asia Pacific Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 543. Asia Pacific Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 544. China Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 545. China Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 546. China Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 547. China Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 548. China Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 549. Japan Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 550. Japan Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 551. Japan Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 552. Japan Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 553. Japan Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 554. India Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 555. India Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 556. India Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 557. India Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 558. India Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 559. South Korea Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 560. South Korea Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 561. South Korea Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 562. South Korea Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 563. South Korea Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 564. Taiwan Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 565. Taiwan Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 566. Taiwan Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 567. Taiwan Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 568. Taiwan Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 569. Australia Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 570. Australia Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 571. Australia Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 572. Australia Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 573. Australia Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 574. Rest of Asia-Pacific Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 575. Rest of Asia-Pacific Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 576. Rest of Asia-Pacific Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 577. Rest of Asia-Pacific Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 578. Rest of Asia-Pacific Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 579. Europe Antimalarial Drug Sales, by Country K Tons (2023-2028)
  • Table 580. Europe Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 581. Europe Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 582. Europe Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 583. Europe Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 584. Europe Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 585. Germany Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 586. Germany Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 587. Germany Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 588. Germany Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 589. Germany Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 590. France Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 591. France Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 592. France Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 593. France Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 594. France Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 595. Italy Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 596. Italy Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 597. Italy Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 598. Italy Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 599. Italy Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 600. United Kingdom Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 601. United Kingdom Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 602. United Kingdom Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 603. United Kingdom Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 604. United Kingdom Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 605. Netherlands Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 606. Netherlands Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 607. Netherlands Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 608. Netherlands Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 609. Netherlands Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 610. Rest of Europe Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 611. Rest of Europe Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 612. Rest of Europe Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 613. Rest of Europe Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 614. Rest of Europe Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 615. MEA Antimalarial Drug Sales, by Country K Tons (2023-2028)
  • Table 616. MEA Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 617. MEA Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 618. MEA Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 619. MEA Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 620. MEA Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 621. Middle East Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 622. Middle East Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 623. Middle East Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 624. Middle East Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 625. Middle East Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 626. Africa Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 627. Africa Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 628. Africa Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 629. Africa Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 630. Africa Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 631. North America Antimalarial Drug Sales, by Country K Tons (2023-2028)
  • Table 632. North America Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 633. North America Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 634. North America Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 635. North America Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 636. North America Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 637. United States Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 638. United States Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 639. United States Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 640. United States Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 641. United States Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 642. Canada Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 643. Canada Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 644. Canada Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 645. Canada Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 646. Canada Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 647. Mexico Antimalarial Drug Sales, by Type K Tons (2023-2028)
  • Table 648. Mexico Antimalarial Drug Sales, by Application K Tons (2023-2028)
  • Table 649. Mexico Antimalarial Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 650. Mexico Antimalarial Drug Sales, by Form K Tons (2023-2028)
  • Table 651. Mexico Antimalarial Drug Sales, by Parasite Type K Tons (2023-2028)
  • Table 652. Antimalarial Drug: by Type(USD/Units)
  • Table 653. Research Programs/Design for This Report
  • Table 654. Key Data Information from Secondary Sources
  • Table 655. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antimalarial Drug: by Type USD Million (2017-2022)
  • Figure 5. Global Antimalarial Drug: by Application USD Million (2017-2022)
  • Figure 6. Global Antimalarial Drug: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Antimalarial Drug: by Form USD Million (2017-2022)
  • Figure 8. Global Antimalarial Drug: by Parasite Type USD Million (2017-2022)
  • Figure 9. South America Antimalarial Drug Share (%), by Country
  • Figure 10. Asia Pacific Antimalarial Drug Share (%), by Country
  • Figure 11. Europe Antimalarial Drug Share (%), by Country
  • Figure 12. MEA Antimalarial Drug Share (%), by Country
  • Figure 13. North America Antimalarial Drug Share (%), by Country
  • Figure 14. Global Antimalarial Drug: by Type K Tons (2017-2022)
  • Figure 15. Global Antimalarial Drug: by Application K Tons (2017-2022)
  • Figure 16. Global Antimalarial Drug: by Distribution Channel K Tons (2017-2022)
  • Figure 17. Global Antimalarial Drug: by Form K Tons (2017-2022)
  • Figure 18. Global Antimalarial Drug: by Parasite Type K Tons (2017-2022)
  • Figure 19. South America Antimalarial Drug Share (%), by Country
  • Figure 20. Asia Pacific Antimalarial Drug Share (%), by Country
  • Figure 21. Europe Antimalarial Drug Share (%), by Country
  • Figure 22. MEA Antimalarial Drug Share (%), by Country
  • Figure 23. North America Antimalarial Drug Share (%), by Country
  • Figure 24. Global Antimalarial Drug: by Type USD/Units (2017-2022)
  • Figure 25. Global Antimalarial Drug share by Players 2022 (%)
  • Figure 26. Global Antimalarial Drug share by Players (Top 3) 2022(%)
  • Figure 27. Global Antimalarial Drug share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer (United States) Revenue: by Geography 2022
  • Figure 31. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Ranbaxy Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 34. Ranbaxy Laboratories (India) Revenue: by Geography 2022
  • Figure 35. Ipca Laboratories Ltd (India) Revenue, Net Income and Gross profit
  • Figure 36. Ipca Laboratories Ltd (India) Revenue: by Geography 2022
  • Figure 37. Zydus Cadila (India) Revenue, Net Income and Gross profit
  • Figure 38. Zydus Cadila (India) Revenue: by Geography 2022
  • Figure 39. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 41. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Novartis AG (Switzerland) Revenue: by Geography 2022
  • Figure 43. Alvizia Health Care (India) Revenue, Net Income and Gross profit
  • Figure 44. Alvizia Health Care (India) Revenue: by Geography 2022
  • Figure 45. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 46. Bayer (Germany) Revenue: by Geography 2022
  • Figure 47. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 48. Roche Holding AG (Switzerland) Revenue: by Geography 2022
  • Figure 49. Global Antimalarial Drug: by Type USD Million (2023-2028)
  • Figure 50. Global Antimalarial Drug: by Application USD Million (2023-2028)
  • Figure 51. Global Antimalarial Drug: by Distribution Channel USD Million (2023-2028)
  • Figure 52. Global Antimalarial Drug: by Form USD Million (2023-2028)
  • Figure 53. Global Antimalarial Drug: by Parasite Type USD Million (2023-2028)
  • Figure 54. South America Antimalarial Drug Share (%), by Country
  • Figure 55. Asia Pacific Antimalarial Drug Share (%), by Country
  • Figure 56. Europe Antimalarial Drug Share (%), by Country
  • Figure 57. MEA Antimalarial Drug Share (%), by Country
  • Figure 58. North America Antimalarial Drug Share (%), by Country
  • Figure 59. Global Antimalarial Drug: by Type K Tons (2023-2028)
  • Figure 60. Global Antimalarial Drug: by Application K Tons (2023-2028)
  • Figure 61. Global Antimalarial Drug: by Distribution Channel K Tons (2023-2028)
  • Figure 62. Global Antimalarial Drug: by Form K Tons (2023-2028)
  • Figure 63. Global Antimalarial Drug: by Parasite Type K Tons (2023-2028)
  • Figure 64. South America Antimalarial Drug Share (%), by Country
  • Figure 65. Asia Pacific Antimalarial Drug Share (%), by Country
  • Figure 66. Europe Antimalarial Drug Share (%), by Country
  • Figure 67. MEA Antimalarial Drug Share (%), by Country
  • Figure 68. North America Antimalarial Drug Share (%), by Country
  • Figure 69. Global Antimalarial Drug: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • GlaxoSmithKline (United Kingdom)
  • Ranbaxy Laboratories (India)
  • Ipca Laboratories Ltd (India)
  • Zydus Cadila (India)
  • Merck KGaA (Germany)
  • Novartis AG (Switzerland)
  • Alvizia Health Care (India)
  • Bayer (Germany)
  • Roche Holding AG (Switzerland)
Select User Access Type

Key Highlights of Report


Jun 2023 211 Pages 52 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antimalarial Drug Quantitative research analysis
Global Antimalarial Drug Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Geriatric Population in Major Economies " is seen as one of major growth factors of Antimalarial Drug Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Antimalarial Drug market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Antimalarial Drug Report?

Have a Query? Click Here

Other Related Reports

Tea Tree Oil Comprehensive Study by Application (Cosmetics, Personal care, Health care, Others), End Use Verticals (Commercial, Household), Distribution Channel (Supermarket and Hypermarkets, Wholesa...
$ 3650
Natural Antioxidants Comprehensive Study by Type (Vitamin A, Vitamin C, Vitamin E, Beta-Carotene, Lycopene, Lutein, Selenium, Manganese, Others), Application (Food & Beverage, Pharmaceuticals, Animal...
$ 3750
Respiratory Disposable Devices Comprehensive Study by Type (Face Masks, Tubes, Filters, Others), Application (Adult, Paediatric & Neonatal), End User (Hospitals, Clinics, Ambulatory Care Centers, Oth...
$ 3650
Smoking Cessation Products Comprehensive Study by Type (Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride, Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral...
$ 3650
Vitamin & Mineral Supplement Comprehensive Study by Type (Vitamin A, Vitamin B, Vitamin C, Vitamin E, Calcium, Iron, Magnesium, Zinc, Others), Application (Food & Beverage, Supplements, Pharmaceutica...
$ 3750
Hepatitis B Vaccines Comprehensive Study by Type (Mono Vaccines, Combination Vaccines), Application (Hospitals, Retail Pharmacy, Online Pharmacy), Vaccine Type (Recombinant Vaccine, Inactivated Vacci...
$ 3350